However, more serious side effects can occur, which should be explored thoroughly with a physician before beginning any medication
Global GLP-1 Receptor Agonist Market Report Coverage Get more details on this report - Request Free Sample PDF Driving Factors Innovative treatments are being developed, which are expected to drive the expansion of the GLP-1 receptor agonist market
Other GLP-1 Agonists Trulicity and Saxenda are two notable GLP-1 receptor agonists that serve as alternatives to semaglutide
Follow-up appointments offer a chance to review lab results, discuss lifestyle changes, and plan future doses
The market is expected to grow from $43,904 million in 2025 at a compound annual growth rate (CAGR) of 13%
Increased GH levels can support protein synthesis, which is the building block for muscle tissue